You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 17, 2024

Details for Patent: 6,992,207

✉ Email this page to a colleague

« Back to Dashboard

Which drugs does patent 6,992,207 protect, and when does it expire?

Patent 6,992,207 protects PEPAXTO and is included in one NDA.

This patent has twelve patent family members in eleven countries.

Summary for Patent: 6,992,207

Title:	Melphalan derivatives and their use as cancer chemotherapeutic drugs
Abstract:	The invention refers to new alkylating di- and tripeptides based on a melphalan unit, and one or two additional amino acids or amino acid derivatives, which can be used in the treatment of carcinogenic diseases. Further, the invention refers to a pharmaceutical composition comprising the alkylating peptides of the invention.
Inventor(s):	Lewensohn; Rolf (Danderyd, SE), Gullbo; Joakim (Uppsala, SE), Larsson; Rolf (Uppsala, SE), Ehrsson; Hans (Bromma, SE), Luthman; Kristina (Gothenburg, SE)
Assignee:	Oncopeptides AB (Danderyd, SE)
Application Number:	10/297,588
Patent Claim Types: see list of patent claims	Use; Composition; Compound;

Drugs Protected by US Patent 6,992,207

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Oncopeptides Ab	PEPAXTO	melphalan flufenamide hydrochloride	POWDER;INTRAVENOUS	214383-001	Feb 26, 2021		DISCN	Yes	No	⤷ Try a Trial	⤷ Try a Trial	Y	Y		IN COMBINATION WITH DEXAMETHASONE TO TREAT RELAPSED OR REFRACTORY MULTIPLE MYELOMA (REFACTORY TO AT LEAST 1 PROTEASOME INHIBITOR, 1 IMMUNOMODULATORY AGENT, AND 1 ANTI-CD38 MAB) IN ADULTS WHO RECEIVED AT LEAST 4 PRIOR LINES OF THERAPY	⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Patented / Exclusive Use	>Submissiondate

Foreign Priority and PCT Information for Patent: 6,992,207

Foriegn Application Priority Data
Foreign Country	Foreign Patent Number	Foreign Patent Date
Sweden	0002202	Jun 13, 2000

PCT Information
PCT Filed	June 11, 2001	PCT Application Number:	PCT/SE01/01318
PCT Publication Date:	December 20, 2001	PCT Publication Number:	WO01/96367

International Family Members for US Patent 6,992,207

Subscribe to access the full database, or Try a Trial
Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Austria	458746	⤷ Try a Trial
Australia	6451501	⤷ Try a Trial
Canada	2408501	⤷ Try a Trial
Germany	60141398	⤷ Try a Trial
>Country	>Patent Number	>Estimated Expiration	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.